The evolutionary advantage of visceral fat helps explain why humans developed this deep abdominal fat store in the first place — and why it remains so persistent today. For most of human history, the ability to rapidly accumulate and mobilise energy reserves was critical for survival during famine, physical hardship, and infection. Visceral fat, with its high metabolic activity and proximity to vital organs, was ideally suited to this role. Yet in modern Britain, where calorie-dense food is abundant and physical demands are low, this once-protective adaptation has become a significant driver of metabolic disease, cardiovascular risk, and type 2 diabetes.

What Is Visceral Fat and How Does It Differ From Other Body Fat?

Visceral fat is stored deep within the abdominal cavity surrounding vital organs, has higher metabolic activity than subcutaneous fat, and functions as an endocrine organ releasing hormones and inflammatory molecules. Waist circumference is the recommended clinical proxy for estimating visceral fat.

Body fat is not a single, uniform tissue. It exists in distinct compartments, each with different locations, functions, and metabolic properties. The two primary types are subcutaneous fat and visceral fat.

Subcutaneous fat sits just beneath the skin and can be felt when you pinch the skin around the abdomen, thighs, or upper arms. It acts as a physical cushion, provides insulation, and stores energy in a relatively stable, metabolically slower manner. In contrast, visceral fat is stored deep within the abdominal cavity, surrounding vital organs such as the liver, pancreas, and intestines. It has significantly higher metabolic activity than subcutaneous fat.

Visceral fat is not simply passive energy storage. It functions similarly to an endocrine organ, releasing a range of hormones and inflammatory signalling molecules known as adipokines and cytokines. These include substances such as interleukin-6 (IL-6), tumour necrosis factor-alpha (TNF-α), leptin, and adiponectin. In excess, these signals can influence insulin sensitivity, systemic inflammation, and cardiovascular function. The role of resistin in humans remains an area of ongoing research and is less clearly established than in animal models.

Unlike subcutaneous fat, visceral fat cannot be directly seen or easily measured without specialist imaging, which is not routinely used in clinical practice solely to quantify visceral fat. Instead, waist circumference is used as a practical proxy. To measure correctly, the tape should be placed midway between the lower rib and the top of the hip bone, at the end of a normal breath out.

According to NHS and NICE guidance, the thresholds indicating increased health risk vary by ethnicity:

• White European, Black African, and most other groups: increased risk at ≥94 cm (37 inches) in men and ≥80 cm (31.5 inches) in women; very high risk at ≥102 cm (40 inches) in men and ≥88 cm (34.5 inches) in women.

• South Asian, Chinese, Japanese, and other high-risk ethnic groups: lower thresholds apply — increased risk at ≥90 cm in men, with the same ≥80 cm threshold for women.

NICE also recommends considering waist-to-height ratio alongside BMI and waist circumference; a ratio below 0.5 is the general target for adults. Understanding what visceral fat is — and how it differs from other fat — is the first step in appreciating both its evolutionary purpose and its modern implications.

The Evolutionary Role of Visceral Fat in Human Survival

Visceral fat offered survival advantages through rapid energy mobilisation via the portal vein to the liver, possible immune support, and organ cushioning during physical hardship. The 'thrifty genotype' hypothesis is one of several competing frameworks explaining this evolutionary trait.

To understand the evolutionary advantage of visceral fat, it is important to consider the environment in which early humans lived. For the vast majority of human evolutionary history — spanning hundreds of thousands of years — food was scarce, unpredictable, and required significant physical effort to obtain. In this context, the ability to store energy efficiently was not merely beneficial; it was essential for survival.

Visceral fat is thought to have offered several distinct survival advantages over other forms of fat storage:

• Rapid energy mobilisation: Visceral fat is sensitive to stress hormones such as adrenaline and cortisol. During periods of famine or physical threat, lipolysis (the breakdown of stored fat) releases fatty acids and glycerol into the circulation. The liver can then use these substrates — including glycerol via gluconeogenesis — to help maintain blood glucose levels. This process is more nuanced than a simple direct conversion of fat to glucose, and the precise efficiency of visceral versus peripheral fat mobilisation in ancestral humans remains an area of ongoing research.

• Proximity to vital organs: Being located close to the liver and digestive organs meant that fatty acids released from visceral stores could be transported directly via the portal vein to the liver — a more direct route than mobilising peripheral fat depots.

• Possible immune and inflammatory support: Some researchers have proposed that the inflammatory molecules released by visceral fat may have helped mount rapid immune responses to infection or injury. This remains a hypothesis rather than an established fact, and the net benefit of visceral fat-derived inflammation in ancestral contexts is debated.

• Organ cushioning: Visceral fat provided a degree of physical protection for abdominal organs during periods of physical hardship. Thermoregulation, by contrast, is primarily a function of subcutaneous fat and specialised brown adipose tissue rather than visceral fat.

From a genetic perspective, individuals who could accumulate visceral fat efficiently during times of plenty — and mobilise it during scarcity — may have been more likely to survive and reproduce. This is sometimes referred to as the 'thrifty genotype' hypothesis, proposed by geneticist James Neel in 1962.^[4] However, it is important to note that this remains one of several competing hypotheses. Alternative frameworks include the 'drifty gene' hypothesis (Speakman, 2008) and the 'thrifty phenotype' hypothesis (Hales and Barker), each offering different explanations for the evolutionary origins of metabolic efficiency and obesity susceptibility. No single hypothesis is universally accepted.

How Modern Lifestyles Have Changed the Impact of Visceral Fat

Modern caloric surplus, physical inactivity, chronic psychological stress, and sleep deprivation prevent visceral fat from being fully mobilised, causing it to accumulate progressively. This creates a mismatch between ancestral biology and contemporary living conditions.

The same biological mechanisms that once conferred a survival advantage have, in the context of modern life, become a source of significant health concern. The core problem is a profound mismatch between our evolutionary biology and contemporary living conditions.

In modern industrialised societies, including the UK, most people have consistent access to calorie-dense, highly processed foods. Physical activity levels have declined with the rise of sedentary occupations, car travel, and screen-based leisure. Chronic psychological stress — from work pressures, financial concerns, and social demands — is associated with persistently elevated cortisol levels. Cortisol is one of the hormones linked to visceral fat accumulation, and research suggests that chronic psychosocial stress is associated with greater central adiposity, though the relationship is complex and not simply one of continuous hormonal elevation.

The body's 'emergency energy reserve' system, designed for intermittent use, is now rarely fully mobilised, because the sustained physical exertion or caloric scarcity that would historically have depleted visceral stores seldom occurs. As a result, visceral fat can accumulate progressively over time.

Additionally, sleep deprivation — increasingly common in modern populations — has been associated with elevated ghrelin (a hunger-stimulating hormone) and reduced leptin (a satiety hormone), further promoting overeating and fat storage. Systematic reviews published in journals such as Sleep and Obesity Reviews have consistently linked shorter sleep duration and poorer sleep quality with increased visceral adiposity.^[7] The NHS advises that most adults need between 6 and 9 hours of sleep per night, though individual needs vary.^[6]

In essence, the evolutionary advantage of visceral fat has become a liability in an environment of chronic caloric surplus, physical inactivity, and persistent psychological stress. Our genes have not changed substantially; our environment has — and the consequences are reflected in rising rates of obesity and metabolic disease across the UK.

Health Risks Associated With Excess Visceral Fat

Excess visceral fat is strongly associated with type 2 diabetes, cardiovascular disease, MASLD, certain cancers, and obstructive sleep apnoea due to its inflammatory activity and proximity to key organs. BMI alone can be misleading, as normal-weight individuals may still carry significant visceral fat.

Excess visceral fat is strongly associated with a cluster of serious, chronic health conditions. Because of its high metabolic activity and proximity to key organs, it exerts effects that go well beyond simple weight gain.

Metabolic and cardiovascular risks include:

• Type 2 diabetes: Visceral fat releases free fatty acids and inflammatory cytokines that are associated with impaired insulin signalling in the liver and muscle tissue, contributing to insulin resistance — a key precursor to type 2 diabetes. NICE guidance on type 2 diabetes prevention (PH38) identifies central obesity as a major modifiable risk factor, and the NHS Diabetes Prevention Programme (Healthier You) offers structured support for those at high risk.^[10]

• Cardiovascular disease: The inflammatory molecules and lipids associated with excess visceral fat are linked to atherosclerosis (the build-up of plaques in arterial walls), raising the risk of heart attack and stroke. NICE guidance on cardiovascular disease risk assessment and management (NG238) identifies abdominal obesity as an independent cardiovascular risk factor.^[11]

• Metabolic dysfunction-associated steatotic liver disease (MASLD), formerly known as NAFLD: Free fatty acids draining from visceral fat directly into the portal circulation can accumulate in the liver, leading to MASLD. UK estimates suggest this condition affects a substantial proportion of adults, though precise prevalence figures vary by study; NICE guidance (NG49) provides current assessment and management recommendations.

• Certain cancers: Evidence from the World Cancer Research Fund (WCRF) and other bodies links excess body fatness and central adiposity with increased risk of colorectal, post-menopausal breast, and endometrial cancers, likely mediated through chronic inflammation and hormonal changes including elevated oestrogen levels.

• Obstructive sleep apnoea (OSA): Fat deposition around the neck and thorax, often accompanying visceral obesity, can obstruct the upper airway during sleep. Common symptoms include loud snoring, witnessed pauses in breathing, and excessive daytime sleepiness. Anyone experiencing these symptoms should speak to their GP, who can refer to a sleep service if appropriate.

It is important to note that BMI alone can be misleading. Some individuals with a 'normal' BMI may carry significant visceral fat — a pattern sometimes described as 'metabolically obese, normal weight'. This underscores the importance of waist circumference and waist-to-height ratio as complementary assessment tools in clinical practice, as recommended by NICE (CG189).

NHS-Recommended Ways to Reduce Visceral Fat Safely

Visceral fat responds well to at least 150 minutes of moderate aerobic activity per week, dietary modification following the NHS Eatwell Guide, stress management, and 6–9 hours of quality sleep. GP referral to structured programmes such as the NHS Diabetes Prevention Programme may be appropriate for those at high metabolic risk.

The encouraging news is that visceral fat, precisely because of its high metabolic activity, tends to respond well to lifestyle interventions — often more readily than subcutaneous fat. The NHS and NICE provide clear, evidence-based guidance on safe and effective approaches.

Physical activity is one of the most powerful tools. Both aerobic exercise (such as brisk walking, cycling, or swimming) and resistance training have been shown to reduce visceral fat, independently of overall weight loss.^[13] The UK Chief Medical Officers' Physical Activity Guidelines recommend at least 150 minutes of moderate-intensity aerobic activity per week, or 75 minutes of vigorous-intensity activity, alongside muscle-strengthening activities on two or more days per week.^[8][9] Reducing prolonged periods of sitting is also advised. Even modest increases in daily movement — taking the stairs, walking during lunch breaks — can contribute meaningfully over time.

Dietary modification should focus on:

• Reducing intake of highly processed foods, refined carbohydrates, and added sugars, which are associated with insulin spikes and visceral fat storage.

• Increasing consumption of fibre-rich foods (vegetables, legumes, and wholegrains), which support gut health and improve insulin sensitivity.

• Moderating alcohol intake, as alcohol is metabolised in the liver and is associated with visceral and hepatic fat accumulation.

• Following a broadly Mediterranean-style dietary pattern, which has good evidence for reducing cardiometabolic risk. The NHS Eatwell Guide provides a practical framework for balanced eating that is appropriate for most adults in the UK.

Stress management and sleep hygiene are often overlooked but clinically important. Techniques such as mindfulness-based stress reduction (MBSR), regular relaxation practices, and aiming for 6–9 hours of quality sleep per night (in line with NHS guidance) can help support healthier cortisol patterns and may reduce visceral fat accumulation over time. Basic sleep hygiene — maintaining a consistent sleep schedule, limiting screen use before bed, and keeping the bedroom cool and dark — is recommended by the NHS.

Individuals concerned about their waist measurement or metabolic health should speak to their GP, who can arrange relevant investigations including fasting glucose, HbA1c (the standard first-line test for assessing blood glucose and diabetes risk in primary care), lipid profile, and liver function tests. Depending on the assessment, referral to a structured weight management programme may be appropriate:

• The NHS Diabetes Prevention Programme (Healthier You) supports people identified as being at high risk of type 2 diabetes.

• Tier 2 and Tier 3 weight management services are commissioned locally and offer behavioural, dietary, and — where appropriate — pharmacological support.

• NICE (CG189) sets out criteria for referral to specialist or bariatric services, which may be considered for individuals with a BMI of 40 or above, or 35 or above with significant obesity-related comorbidities, where other interventions have not been effective.

Early intervention remains the most effective strategy for preventing the long-term complications associated with excess visceral fat.

Frequently Asked Questions